Mitchell Shirvan
CSO and CDO · Silexion Therapeutics Corp
IndividualSelling only
- 2026
- Jun 8, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Mitchell Shirvan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- HRTG GPE, LLC - $50.00M in KARD purchases and sales in the last 12 months
- Redmile Group, LLC - $49.64M in ADCT purchases and sales in the last 12 months
- Casdin Partners Master Fund, L.P. - $49.54M in BLFS purchases and sales in the last 12 months
- Gary S. Guthart - $48.79M in ISRG purchases and sales in the last 12 months
- Robert B. Ford - $48.22M in ABT purchases and sales in the last 12 months
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mitchell Shirvan?
Mitchell Shirvan is a corporate insider, tracked as CSO and CDO of Silexion Therapeutics Corp (SLXN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mitchell Shirvan last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 3 filings going back to 2026.
Has Mitchell Shirvan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($31K) across all tracked filings.
